Follow the MediPharm Labs Corp. stock price and the full directors' dealings record of the company, a listed equity based in Canada. Shares are quoted on CA CA, under the supervision of SEDI. Market capitalisation: €29.7m. The latest transaction was disclosed on 16 June 2026 (57 - Exercise of rights). Among the most active insiders: Hunter, Gregory Edison. All data is accessible without an account.
19
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
23Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,930 of 26,334 companies
16.2
score / 100
Value
10
Quality
22
FCF yld-18%
Earn yld-26%
EV/EBITDA·
ROE-22%
Gross mgn31%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
MediPharm Labs Corp. is a company focused on the production of cannabinoids for medical purposes. It is listed on the Toronto Stock Exchange under the symbol XTSE.